U.S. Life Sciences Stock News

If you are wondering whether Allison Transmission Holdings at around US$118 a share still offers value, the starting point is understanding what the current price is really baking in. The stock has been volatile recently, with a 4.3% gain over the last week, a 7.1% decline over the last month, and returns of 19.6% year to date and 16.8% over the past year that may catch your eye. These moves sit against a backdrop of ongoing interest in capital goods companies and how investors are pricing...

Q1 miss puts SouthState Bank (SSB) under closer investor scrutiny SouthState Bank (SSB) recently reported a softer quarter, missing analyst expectations for revenue and net interest income, and the stock has slipped 3.4% since the release. The weaker print arrives as regional banks contend with fintech competition, deposit outflows, credit quality concerns, and higher regulatory costs. This keeps investors focused on how efficiently each bank manages earnings and balance sheet risk. See our...

Earlier this week, Canaccord Genuity initiated coverage on Pulse Biosciences with a buy rating, highlighting its nanosecond pulsed field ablation platform for cardiac applications and its potential for meaningful commercial adoption. In a parallel development, top executives acquired a combined 675,233 shares via the company’s at-the-market equity offering program, underscoring insider confidence in the technology’s commercial prospects. Next, we’ll examine how Canaccord Genuity’s backing of...

SunPower’s equity and debt moves SunPower (SPWR) has moved to close a US$40.7 million shelf registration and is now seeking to pay upcoming interest on its 2029 convertible notes in stock plus bonus shares instead of cash. This combination of equity capacity, proposed share-based interest payments, and a recent incremental investment from Fortis Capital is intended to give the company more room to manage liquidity through Q3 2026. See our latest analysis for SunPower. Recent announcements...

If you are wondering whether Datadog's share price still makes sense after a strong run, the key question is how that price compares with what the business might be worth. The stock last closed at US$243.60, with returns of 8.2% over 7 days, 67.2% over 30 days, 82.1% year to date, 100.1% over 1 year, 153.7% over 3 years and 157.8% over 5 years. That performance naturally raises questions about how much future performance is already reflected in the price. Recent attention on Datadog has...

Charles River Laboratories International recently presented at the William Blair Growth Stock Conference in Chicago and the Jefferies Global Healthcare Conference in New York, outlining its current strategic focus, business developments, and recent trends via live and archived webcasts for investors. These appearances highlighted CEO Birgit Girshick’s new “Pathway to Purpose” framework and ongoing portfolio reshaping, including divestitures of CDMO, Cell Solutions, and selected European...

Earlier this week, Raymond James upgraded Atlas Energy Solutions from Market Perform to Outperform after the company reported first-quarter 2026 results and detailed expanded distributed power growth plans, including a global framework agreement with Caterpillar for 1.4 GW of power capacity and a US$450 million convertible senior notes offering to fund expansion toward 2 GW. The upgrade underscores how Atlas is increasingly being viewed not just as a Permian proppant and logistics provider,...

In recent days, Conagra Brands reported quarterly results with slightly lower year-over-year revenue that still exceeded analyst expectations, alongside mixed profit guidance affected by commodity cost pressures. At the same time, several analysts warned that persistent inflation and a high payout ratio could put Conagra’s dividend policy under scrutiny, even as insiders accepted additional equity awards. We’ll now examine how concerns about inflation-driven cost pressures and potential...

Why Pinterest’s $4 Billion AWS Deal Matters for the Stock Pinterest (PINS) has committed US$4b to Amazon Web Services through 2031, its largest infrastructure agreement to date, to support AI model development, faster search and shopping, and global platform modernization. See our latest analysis for Pinterest. The AWS commitment lands after a volatile stretch for Pinterest, with the share price up 4.5% over the past week and 7.9% over 90 days, yet down 18.7% year to date and a 36.1% total...

Clinical data catalyst and recent stock move Enliven Therapeutics (ELVN) is back in focus after the company highlighted upcoming Phase 1 ENABLE trial data for ELVN-001 in chronic myeloid leukemia, set to be presented at the European Hematology Association Congress. The company plans a June 11 webcast to walk through the updated results. This, together with recent positive analyst commentary, has drawn fresh attention to a stock that is up 66.1% over the past year. See our latest analysis for...

Recently, Credicorp reported a strong first quarter with a 21.1% return on equity and declared a record dividend of 50 soles per share, citing robust solvency and confidence in its business trajectory. The company’s dividend yield now stands well above industry and S&P 500 averages, underpinned by several years of dividend growth and earnings that analysts view as supportive of ongoing payouts. Next, we’ll examine how Credicorp’s record dividend and solid first-quarter profitability...

Recent price moves and renewed interest in Qualys Recent gains in Qualys (QLYS) have drawn fresh attention, as the stock rose 11.1% over the past week and 21.0% over the past month, even as longer term returns remain weaker. This move comes as some valuation models suggest the shares trade below certain fair value estimates. This has prompted some investors to reassess the cybersecurity and cloud-based security provider's positioning within their portfolios. See our latest analysis for...

In late May and early June 2026, Agios Pharmaceuticals halted development of tebapivat in lower-risk myelodysplastic syndromes, gained European Commission approval for PYRUKYND (mitapivat) in thalassemia across all EU member states, and licensed exclusive global rights to cevidoplenib, an oral SYK inhibitor, from Oscotec for immune thrombocytopenia and other indications. Together, these updates reshape Agios’s mix of commercial products and pipeline assets, trading one unpromising program...

Grupo Aeroméxico, listed as NYSE:AERO, reported record weekly sales in May 2026, the highest in the company’s history. The record sales coincided with growing passenger traffic for May 2026 across both international and domestic routes. The update points to strong travel demand and a meaningful shift in recent operating activity for the airline. For you as an investor, this update reinforces Grupo Aeroméxico’s position as a major Mexican carrier with meaningful exposure to both domestic and...

Aon has recently strengthened its leadership bench, appointing Alberto Carrion as head of Lenders Solutions, Helene Madell as chief executive of its Global Broking Centre, and Herlina Surya as a power adviser in Indonesia, while also publishing new insights on AI-driven human capital trends and rising M&A transaction insurance claims. Together, these moves highlight Aon’s focus on complex risk advisory, middle-market and infrastructure clients, and fast-evolving workforce and AI-related...

In the past few days, Greenbrier Companies reported quarterly results showing a 22.9% year-on-year revenue drop and revenue falling 11.5% short of analyst expectations, alongside weaker full-year revenue and EPS guidance than previously anticipated. This combination of softer current performance and a more cautious outlook has raised fresh questions about how resilient Greenbrier’s railcar and leasing businesses may be against industry headwinds and cost pressures. Next, we’ll examine how...

If you are wondering whether Microchip Technology at around US$96.30 is still offering value or if the easier gains are behind it, this breakdown will help you weigh what the current price really implies. The stock is roughly flat over the past week with a 0.3% gain, a little softer over the last month with a 2.2% decline, yet stands out with returns of 48.1% year to date and 53.7% over the past year. Recent coverage has focused on Microchip Technology's role within the broader semiconductor...

Teledyne Technologies (TDY) has been back in focus after Teledyne FLIR Defense secured an $11.2 million U.S. Army contract for advanced CBRN drone kits and Teledyne HiRel Semiconductors introduced a new space qualified low noise amplifier. See our latest analysis for Teledyne Technologies. Despite a modest 1-day share price return of 0.09% and recent share price softness over the past quarter, Teledyne Technologies still carries a 19.24% year to date share price return and a 23.71% 1-year...

OneMain Holdings (NYSE:OMF) has launched its first consumer loan asset backed securities securitization of 2026. This transaction is the company's 32nd consumer loan ABS issuance since 2013. The new deal has attracted ratings coverage, adding a fresh data point for investors tracking OneMain's funding mix. For investors watching consumer finance, OneMain sits at the intersection of personal lending and structured credit. The company uses consumer loan ABS as a recurring funding tool. The...

Veeva Systems (VEEV) kicked off Q1 2027 with revenue of US$882.9 million and basic EPS of US$1.60, against a backdrop of trailing 12 month EPS of US$5.75 and total revenue of about US$3.3 billion that has been reported growing around 11.2% year over year. Over recent quarters, revenue has moved from US$759.0 million in Q1 2026 through US$835.9 million in Q4 2026 to US$882.9 million in Q1 2027, while basic EPS has shifted from US$1.40 to US$1.49 and then to US$1.60 over the same period,...

Nvidia CEO Jensen Huang’s recent GTC Taipei keynote at Computex, which reframed the scale and duration of the AI chip cycle and confirmed its next data center platform, has renewed interest in AI-related semiconductor suppliers such as Allegro MicroSystems. This matters because Allegro’s exposure to automotive, industrial and data center power and sensing solutions ties its longer-term prospects more closely to how far AI infrastructure spending extends beyond core GPUs. With Allegro...

Dividend event puts Hancock Whitney (HWC) in focus Hancock Whitney (HWC) is approaching an ex-dividend date within the next few days, with investors eyeing the upcoming US$0.50 per share payment and the bank's history of paying dividends. See our latest analysis for Hancock Whitney. Recent trading has been supportive, with the share price at US$69.18 and a 90 day share price return of 10.05%. The 1 year total shareholder return of 33.77% and 3 year total shareholder return of 77.05% suggest...

Why Baldwin Insurance Group has investors’ attention Baldwin Insurance Group (BWIN) has been drawing attention after its recent rebrand from BRP Group, shifting to a name that directly reflects its core insurance operations and broader multi-segment model. For investors, the focus now is on how this insurance distribution firm’s mix of advisory, underwriting and mainstreet solutions lines up with a share price of US$19.24 and a market value of about US$2.68b. See our latest analysis for...

Cognyte Software (CGNT) opened Q1 2027 with revenue of US$105.5 million and a basic EPS loss of US$0.04, while the trailing twelve months show revenue of US$410.0 million and a basic EPS loss of US$0.04. Over recent quarters, revenue has moved from US$95.5 million in Q1 2026 to US$105.5 million in Q1 2027, as quarterly EPS has swung between a loss of US$0.07 and a profit of US$0.05. This sets up a picture where investors are likely to focus squarely on how the current loss profile is...